These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38383412)

  • 1. Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype.
    Ma W; Zhou T; Song M; Liu J; Chen G; Zhan J; Ji L; Luo F; Gao X; Li P; Xia X; Huang Y; Zhang L
    J Transl Med; 2024 Feb; 22(1):189. PubMed ID: 38383412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer.
    Li F; Yang Y; Xu Y; Li K; Song L; Xue Y; Dong D
    Medicine (Baltimore); 2023 Jan; 102(4):e32781. PubMed ID: 36705391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genomic profiling of combined small cell lung cancer.
    Zhang J; Zhang L; Luo J; Ge T; Fan P; Sun L; Hou L; Li J; Yu H; Wu C; Zhu Y; Wu C; Jiang G; Troncone G; Malhotra J; Okuda K; Santarpia M; Zamarchi R; Goto T; Cardona AF; Xu J; Chen Q; Zhang Z; Zhang P;
    Transl Lung Cancer Res; 2021 Feb; 10(2):636-650. PubMed ID: 33718010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
    Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
    Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of combined small cell lung carcinoma with unique morphology: Investigation of tumorigenesis.
    Asahina M; Fukumura Y; Mamat O; Saito T; Hayashi T; Uekusa T; Suzuki K; Yao T
    Pathol Int; 2018 Nov; 68(11):618-623. PubMed ID: 30311995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.
    Shi X; Duan H; Liu X; Zhou L; Liang Z
    Oncotarget; 2016 Jun; 7(23):34240-9. PubMed ID: 27145273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Small Cell Carcinoma of the Lung: Is It a Single Entity?
    Zhao X; McCutcheon JN; Kallakury B; Chahine JJ; Pratt D; Raffeld M; Chen Y; Wang C; Giaccone G
    J Thorac Oncol; 2018 Feb; 13(2):237-245. PubMed ID: 29101056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
    Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
    PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.
    Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
    Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma.
    Zhou Z; Zhu L; Niu X; Shen S; Zhao Y; Zhang J; Ye J; Han-Zhang H; Liu J; Liu C; Lu S
    Thorac Cancer; 2019 Apr; 10(4):839-847. PubMed ID: 30793508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genetic analysis of histological components of combined small cell carcinoma.
    Iida Y; Nakanishi Y; Shimizu T; Nomoto M; Nakagawa Y; Ito R; Takahashi N; Masuda S; Gon Y
    Thorac Cancer; 2022 Aug; 13(16):2362-2370. PubMed ID: 35815661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
    Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
    Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
    Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
    Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.
    Hermans BCM; Derks JL; Hillen LM; van der Baan I; van den Broek EC; von der Thüsen JH; van Suylen RJ; Atmodimedjo PN; den Toom TD; Coumans-Stallinga C; Timens W; Dinjens WNM; Dubbink HJ; Speel EM; Dingemans AC;
    Int J Cancer; 2022 Mar; 150(5):802-815. PubMed ID: 34674268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.
    Buys TP; Aviel-Ronen S; Waddell TK; Lam WL; Tsao MS
    J Thorac Oncol; 2009 Feb; 4(2):227-39. PubMed ID: 19179901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
    Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
    PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small-cell lung cancer.
    Hao L; Chen H; Wang L; Zhou H; Zhang Z; Han J; Hou J; Zhu Y; Zhang H; Wang Q
    Thorac Cancer; 2023 Apr; 14(11):1036-1041. PubMed ID: 36810856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
    Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis.
    Walter RF; Werner R; Ting S; Vollbrecht C; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J; Mairinger FD
    Oncotarget; 2015 Sep; 6(28):24690-8. PubMed ID: 26008974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
    Ogino A; Choi J; Lin M; Wilkens MK; Calles A; Xu M; Adeni AE; Chambers ES; Capelletti M; Butaney M; Gray NS; Gokhale PC; Palakurthi S; Kirschmeier P; Oxnard GR; Sholl LM; Jänne PA
    Mol Oncol; 2021 Jan; 15(1):27-42. PubMed ID: 32191822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.